Skip to main content
Erschienen in: Pediatric Surgery International 2/2013

01.02.2013 | Original Article

Correlation between multiple RET mutations and severity of Hirschsprung’s disease

verfasst von: Kunihiro Ishii, Takashi Doi, Ken Inoue, Manabu Okawada, Geoffrey J. Lane, Atsuyuki Yamataka, Chihiro Akazawa

Erschienen in: Pediatric Surgery International | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The enteric nervous system (ENS), comprising neurons and glial cells, organized as interconnected ganglia within the gut wall, controls peristalsis and the production of secretions. The RET receptor tyrosine kinase is expressed throughout enteric neurogenesis and is required for normal ENS development. Humans with mutations in the RET locus have Hirschsprung’s disease (HSCR), and mice lacking RET exhibit total intestinal aganglionosis. Although a number of mutations with the potential for causing HSCR have been reported, their precise correlation with phenotype and symptom severity in HSCR is not clearly understood. Our study investigates the correlation between mutations in the RET locus and symptom severity in HSCR.

Methods

We performed a comprehensive nucleotide analysis of the RET coding region in 18 HSCR patients and 87 controls, performed cellular biological analysis by Western blotting using the expression vector, and analyzed cell proliferation with anti-Ki67 antibody under immunofluorescence confocal microscopy (ICM).

Results

We identified three novel mutations, D489N, L769L, and V778D in the RET coding region in our HSCR patients. In the allelic distribution of D489N and L769L, the difference between HSCR patients and controls reached statistical significance (p = 0.0373 and p = 0.0004, respectively), whereas no statistical difference was observed in the allelic distribution of V778D (p = 0.1073). One HSCR patient who died from total colonic aganglionosis had a combination of homozygous mutation of D489N, L769L, and heterozygous mutation of V778D. Western blotting of full mutant RET from this patient showed significantly increased 150kD-band, which corresponds to the immature form compared with wild-type and single mutant RET. ICM showed that overexpression of full mutant RET significantly reduced cellular proliferation in comparison with wild-type and single mutant RET.

Conclusion

A combination of mutations in the RET locus may correlate with symptom severity in HSCR as a consequence of reduced cellular proliferation secondary to altered maturation of RET.
Literatur
1.
Zurück zum Zitat Amiel J, Sproat-Emison E, Garcia-Barcelo M et al (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45:1–14PubMedCrossRef Amiel J, Sproat-Emison E, Garcia-Barcelo M et al (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45:1–14PubMedCrossRef
2.
Zurück zum Zitat Emison ES, McCallion AS, Kashuk CS et al (2005) A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434(7035):857–863PubMedCrossRef Emison ES, McCallion AS, Kashuk CS et al (2005) A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434(7035):857–863PubMedCrossRef
3.
Zurück zum Zitat Passarge E (2002) Dissecting Hirschsprung disease. Nat Genet 31(1):11–12 Epub 2002 Apr 15PubMed Passarge E (2002) Dissecting Hirschsprung disease. Nat Genet 31(1):11–12 Epub 2002 Apr 15PubMed
4.
Zurück zum Zitat Taraviras S, Marcos-Gutierrez CV, Durbec P et al (1999) Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126(12):2785–2797PubMed Taraviras S, Marcos-Gutierrez CV, Durbec P et al (1999) Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126(12):2785–2797PubMed
5.
Zurück zum Zitat Uesaka T, Jain S, Yonemura S et al (2007) Conditional ablation of GFRalpha1 in postmigratory enteric neurons triggers unconventional neuronal death in the colon and causes a Hirschsprung’s disease phenotype. Development 134(11):2171–2181PubMedCrossRef Uesaka T, Jain S, Yonemura S et al (2007) Conditional ablation of GFRalpha1 in postmigratory enteric neurons triggers unconventional neuronal death in the colon and causes a Hirschsprung’s disease phenotype. Development 134(11):2171–2181PubMedCrossRef
6.
Zurück zum Zitat Sánchez-Mejías A, Fernández RM, López-Alonso M et al (2010) New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease. Genet Med 12(1):39–43PubMedCrossRef Sánchez-Mejías A, Fernández RM, López-Alonso M et al (2010) New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease. Genet Med 12(1):39–43PubMedCrossRef
7.
Zurück zum Zitat Pan ZW, Lou J, Luo C et al (2011) Association analysis of the SOX10 polymorphism with Hirschsprung disease in the Han Chinese population. J Pediatr Surg 46(10):1930–1934PubMedCrossRef Pan ZW, Lou J, Luo C et al (2011) Association analysis of the SOX10 polymorphism with Hirschsprung disease in the Han Chinese population. J Pediatr Surg 46(10):1930–1934PubMedCrossRef
8.
Zurück zum Zitat Avantaggiato V, Dathan NA, Grieco M et al (1994) Developmental expression of the RET protooncogene. Cell Growth Differ 5(3):305–311PubMed Avantaggiato V, Dathan NA, Grieco M et al (1994) Developmental expression of the RET protooncogene. Cell Growth Differ 5(3):305–311PubMed
9.
Zurück zum Zitat Takahashi M, Asai N, Iwashita T et al (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8(11):2925–2929PubMed Takahashi M, Asai N, Iwashita T et al (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8(11):2925–2929PubMed
10.
Zurück zum Zitat Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3(5):383–394PubMedCrossRef Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3(5):383–394PubMedCrossRef
11.
Zurück zum Zitat Gustin JA, Yang M, Johnson EM Jr et al (2007) Deciphering adaptor specificity in GFL-dependent RET-mediated proliferation and neurite outgrowth. J Neurochem 102(4):1184–1194PubMedCrossRef Gustin JA, Yang M, Johnson EM Jr et al (2007) Deciphering adaptor specificity in GFL-dependent RET-mediated proliferation and neurite outgrowth. J Neurochem 102(4):1184–1194PubMedCrossRef
12.
Zurück zum Zitat Bordeaux MC, Forcet C, Granger L et al (2000) The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 19(15):4056–4063PubMedCrossRef Bordeaux MC, Forcet C, Granger L et al (2000) The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 19(15):4056–4063PubMedCrossRef
13.
Zurück zum Zitat Schuchardt A, D’Agati V, Larsson-Blomberg L et al (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367(6461):380–383PubMedCrossRef Schuchardt A, D’Agati V, Larsson-Blomberg L et al (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367(6461):380–383PubMedCrossRef
14.
Zurück zum Zitat Uesaka T, Nagashimada M, Yonemura S et al (2008) Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest 118(5):1890–1898PubMedCrossRef Uesaka T, Nagashimada M, Yonemura S et al (2008) Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest 118(5):1890–1898PubMedCrossRef
15.
Zurück zum Zitat Kjaer S, Ibáñez CF (2003) Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet 12(17):2133–2144PubMedCrossRef Kjaer S, Ibáñez CF (2003) Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet 12(17):2133–2144PubMedCrossRef
16.
Zurück zum Zitat Auricchio A, Griseri P, Carpentieri ML et al (1999) Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet 64(4):1216–1221PubMedCrossRef Auricchio A, Griseri P, Carpentieri ML et al (1999) Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet 64(4):1216–1221PubMedCrossRef
17.
Zurück zum Zitat Wu TT, Tsai TW, Chu CT et al (2005) Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan. J Hum Genet 50(4):168–174PubMedCrossRef Wu TT, Tsai TW, Chu CT et al (2005) Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan. J Hum Genet 50(4):168–174PubMedCrossRef
18.
Zurück zum Zitat Garcia-Barceló MM, Sham MH, Lui VC et al (2003) Chinese patients with sporadic Hirschsprung’s disease are predominantly represented by a single RET haplotype. J Med Genet 40(11):e122PubMedCrossRef Garcia-Barceló MM, Sham MH, Lui VC et al (2003) Chinese patients with sporadic Hirschsprung’s disease are predominantly represented by a single RET haplotype. J Med Genet 40(11):e122PubMedCrossRef
19.
Zurück zum Zitat Sangkhathat S, Kusafuka T, Chengkriwate P et al (2006) Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. J Hum Genet 51(12):1126–1132PubMedCrossRef Sangkhathat S, Kusafuka T, Chengkriwate P et al (2006) Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. J Hum Genet 51(12):1126–1132PubMedCrossRef
20.
Zurück zum Zitat Iwashita T, Kurokawa K, Qiao S et al (2001) Functional analysis of RET with Hirschsprung mutations affecting its kinase domain. Gastroenterology 121(1):24–33PubMedCrossRef Iwashita T, Kurokawa K, Qiao S et al (2001) Functional analysis of RET with Hirschsprung mutations affecting its kinase domain. Gastroenterology 121(1):24–33PubMedCrossRef
21.
Zurück zum Zitat Diaz-Rodriguez E, García-Lavandeira M, Perez-Romero S et al (2011) Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells. Oncogene 31(23):2824–2835PubMedCrossRef Diaz-Rodriguez E, García-Lavandeira M, Perez-Romero S et al (2011) Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells. Oncogene 31(23):2824–2835PubMedCrossRef
Metadaten
Titel
Correlation between multiple RET mutations and severity of Hirschsprung’s disease
verfasst von
Kunihiro Ishii
Takashi Doi
Ken Inoue
Manabu Okawada
Geoffrey J. Lane
Atsuyuki Yamataka
Chihiro Akazawa
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 2/2013
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-012-3196-1

Weitere Artikel der Ausgabe 2/2013

Pediatric Surgery International 2/2013 Zur Ausgabe

Letter to the Editor

Our response to Letter

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.